Product Information
Registration Status: ActiveSIN15830P
LORVIQUA FILM-COATED TABLET 25MG is approved to be sold in Singapore with effective from 2019-10-16. It is marketed by PFIZER PTE LTD, with the registration number of SIN15830P.
This product contains Lorlatinib 25 MG in the form of TABLET, FILM COATED. It is approved for ORAL use.
This product is manufactured by Pfizer Manufacturing Deutschland GmbH in GERMANY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Lorlatinib has been used in trials studying the basic science and treatment of Non-small Cell Lung Cancer and ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC.
Active Ingredient/Synonyms
Lorlatinib | Lorlatinib |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.